These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22399303)

  • 1. Venous and arterial thrombosis associated with HIV infection.
    Dentali F; Nicolini E; Ageno W
    Semin Thromb Hemost; 2012 Jul; 38(5):524-9. PubMed ID: 22399303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy.
    Auerbach E; Aboulafia DM
    Semin Thromb Hemost; 2012 Nov; 38(8):830-8. PubMed ID: 23041980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
    Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
    Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
    Barbaro G
    Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study.
    Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Solinas P; Mannazzu M; Falchi A; Mura MS; Madeddu G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):375-83. PubMed ID: 16584508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans.
    Fultz SL; McGinnis KA; Skanderson M; Ragni MV; Justice AC
    Am J Med; 2004 Mar; 116(6):420-3. PubMed ID: 15006592
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus infection and acute deep vein thromboses.
    Louw S; Jacobson BF; Büller H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):352-5. PubMed ID: 17895501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased cardiovascular risk in HIV patients].
    Wierema TK
    Ned Tijdschr Geneeskd; 2010; 154():A788. PubMed ID: 20456808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous and arterial thrombosis in patients with HIV infection.
    Micieli E; Dentali F; Giola M; Grossi P; Venco A; Ageno W
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):259-63. PubMed ID: 17413763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and coronary heart disease: time for a better understanding.
    Boccara F; Lang S; Meuleman C; Ederhy S; Mary-Krause M; Costagliola D; Capeau J; Cohen A
    J Am Coll Cardiol; 2013 Feb; 61(5):511-23. PubMed ID: 23369416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.